期刊文献+

分离纯化眼镜蛇蛇毒因子的一种经济方法 被引量:6

An economical method for fractionation and purification ofcobra venom factor from the venom of Naja naja atra
下载PDF
导出
摘要 将较大批量的眼镜蛇粗毒依次通过SephadexG75,DEAE-celluloseDE52和Bio-GelP200柱层析可高效地分离纯化眼镜蛇蛇毒因子(CVF),50g粗毒可制备电泳纯CVF960mg,产率大大高于既往文献报道,整个制备过程仅需时数日。通过SDS聚内烯酰胺凝胶电泳测得其分子量为226000,其溶血活性从抗补体活性均与文献报道相近。所以,本实为一种经济,高效的实验室大量制备CVF的方法。 An efficient method for fractionationand purification of cobra venom factor (CVF) fromthe venom of Naja naja atra by successive chromato-graphy on Sephadex G75, DEAE-cellulose DE52 andBioGel P200 columns was reported in detail.Homogeneity of the CVF obtained was shown as asingle band by both immuno-electrophoresis andpolyacrylamide disc-electrophoresis. The yield was1.92%, i.e. 960 mg obtained from 50 g of crudevenom, much higher than that ever reported. Thewhole procedure of fractionation was completed with-in 3 days. Its relative molecular weight was estimatedto be 226000 composed of 3 subunits by SDS-polyacrylamide gel electrophoresis. lts hemolytic andanticomplementary activities were found as potent asreported else where. The newly developed method is ex-pected to be economically significant for mass produc-tion of CVF in laboratory for chronic in vivopharmacologic experiments.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 1994年第4期271-275,共5页 Chinese Journal of Pharmacology and Toxicology
关键词 眼镜蛇毒液类 中华眼镜蛇 补体 色谱法 cobra venoms Naja naja atra complement chromatography
  • 相关文献

同被引文献44

  • 1左长清,林振桃,孔天翰.中华眼镜蛇毒组分CⅡ诱导多药耐药白血病细胞K562/A02凋亡[J].广州医学院学报,2004,32(3):26-30. 被引量:14
  • 2韦世秀.广西眼镜蛇毒对人类小涎腺腺样囊性癌细胞株的抑制作用[J].中国现代医学杂志,2006,16(21):3231-3234. 被引量:7
  • 3SUN Qian-Yun LU Qiu-Min WANG Wan-Yu XIONG Yu-Liang.A highly active anticomplement factor from the venom of naja kaouthia[J].Acta Biochinica et Biophysica Sinica(生物化学与生物物理学报:英文版),2001,33(5):483-8.
  • 4叶春玲,黄守坚,孙家钧,吴楚坤.眼镜蛇毒因子对大鼠油酸型肺损伤的保护作用[J].中国药理学与毒理学杂志,1997,11(1):50-51. 被引量:4
  • 5Eggertsen G, Lind P, Sjoequist J. Molecular characterization of the complement activating protein in the venom of the indian cobra (Naja N. Siamensis). Mol Immunol, 1981;18(2):125-33.
  • 6Vogel CW, Müller-Eberhard HJ. Cobra venom factor: Improved method for purification and biochemical characterization.J Immunol Methods, 1984;73(1):203-20.
  • 7Goetze O, Müller-Eberhard HJ. The C3 activator system; An alternate pathway of complement activation. J Exp Med,1971; 134(3): 90S-108S.
  • 8Hunsicker LG, Ruddy S, Austen KF. Alternate complement pathway: Factors involved in cobra venom factor (CoVF) activation of the third component of complement(C3). J Immunol,1973;110(1) :128-38.
  • 9Pickering RJ, Wolfson MR, Good RA, Gewurz H. Passive hemolysis by serum and cobra venom factor: A new mechanism inducing membrane damage by complement. Microbiology, 1969:62:521-7.
  • 10Miyama A, Kato T, Minoda I, Ueda T et al. Activation of terminal components of human complement by a trypsin-activated complex of human factor B and cobra venom factor. Jpn J Microbiol, 1976;20(6):507-16.

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部